Cited by 39Endometriosis Research and TreatmentReproductive Health and TechnologiesEctopic Pregnancy Diagnosis and Management

Efficacy and safety of intrauterine insemination in patients with moderate-to-severe endometriosis

Open access
van der Houwen, Lisette E.E., Schreurs, Anneke M.F., Schats, Roel, Heymans, Martijn W., Lambalk, Cornelis B., Hompes, Peter G.A., Mijatovic, Velja·2014·Reproductive BioMedicine Online

Abstract

Performing intrauterine insemination (IUI) in moderate-to-severe endometriosis patients is not implemented in international guidelines, as only limited data exist on treatment efficacy and safety. This retrospective study examined the efficacy and safety of two IUI treatment strategies performed between January 2007 and July 2012 in moderate-to-severe endometriosis patients. Eight (40.0%) versus seven (15.6%) ongoing pregnancies were accomplished in patients undergoing IUI with ovarian stimulation (n=20, 61 cycles) versus IUI without ovarian stimulation in the first three cycles followed by IUI with ovarian stimulation (IUI with natural/ovarian stimulation; n=45, 184 cycles). Preceding long-term pituitary down-regulation tended to result in a higher ongoing pregnancy rate (adjusted HR 1.8) and a higher chance of endometriosis recurrence (adjusted HR 2.3). Eight (40.0%) versus 16 (35.6%) recurrences of endometriosis complaints were reported in patients receiving IUI with ovarian stimulation versus IUI with natural/ovarian stimulation. IUI might be a valuable treatment in moderate-to-severe endometriosis patients and IUI with ovarian stimulation should be offered over IUI with natural/ovarian stimulation. Preceding long-term pituitary down-regulation might positively influence the ongoing pregnancy rate and can be considered. Whether this treatment strategy can be structurally offered prior to IVF must be investigated in a randomized controlled trial.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.rbmo.2014.01.005

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The value of IUI in infertile women with rASRM stage III/IV endometriosis with tubal patency is uncertain.

    “Although the value of IUI in infertile women with rASRM stage III/IV endometriosis with tubal patency is uncertain, the use of IUI with ovarian stimulation could be considered (van der Houwen et al., 2014).”

    From ESHRE guideline: endometriosis (2022) · cites this paper as van der Houwen et al., 2014

  • The risk of endometriosis recurrence appears to be increased by IUI and was reported to be higher than after IVF.

    “Lastly, the risk of endometriosis recurrence appears to be increased by IUI (Van der Houwen et al., 2014) and was reported to be higher than after IVF D’Hooghe et al., (2006).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Macer, M.L., Taylor, H.S., 2012. Endometriosis and infertility: a review of pathogenesis and treatment of endometriosis associ- ated infertility. Obstet. Gynecol. Clin. North Am. 39, 535-549.

Cited by

Sorted by citations

Authors
van der Houwen, L. E. E., Schreurs, A. M. F., Schats, R., Heymans, M. W., Lambalk, C. B., Hompes, P. G. A., & Mijatovic, V.
Affiliations
Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Venue
Reproductive BioMedicine Online
Publisher
Elsevier BV
Published
2014-05
Volume
28
Issue
5
Pages
590-598
ISSN
1472-6483 (ISSN-L)
OpenAlex
W2127719966
Cited by
39
References
2
Citations by year
2026: 2 · 2024: 5 · 2023: 2 · 2022: 5 · 2021: 3 · 2020: 1 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 1 · 2015: 3 · 2014: 2
FWCI
4.03
Type
journal article
Language
en
Open access
Locations
  • Reproductive BioMedicine Online (publishedVersion)
  • PubMed (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • VU Research Portal (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ectopic Pregnancy Diagnosis and Management
Keywords
intrauterine insemination, endometriosis, ovulation induction, pituitary down-regulation, endometriosis recurrence, ongoing pregnancy rate, infertility treatment, treatment safety, treatment efficacy, GnRH antagonist protocol, GnRH agonist protocol
MeSH terms
Adult, Endometriosis, Female, Humans, Infertility, Female, Insemination, Artificial, Male, Ovarian Diseases, Pregnancy, Retrospective Studies, Severity of Illness Index, Treatment Outcome, Pregnancy Rate, Time-to-Pregnancy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review